EUVIMEDEUVIMED entdecken
Crossref

Dynamic biomarkers of kidney function in patients with newly diagnosed multiple myeloma receiving daratumumab‐based combination therapy

Poy Theprungsirikul iD, Api Chewcharat, Ayumi Takakura, Shahrier Hossain iD, Ava Kim, Mia B Rubman, Sophia L Wells, Kiana M Zargari, Robert S Rider, Ji Hyun Lee iD, Raad B Chowdhury, Abdullah Jalal iD und 4 weitere

British Journal of Haematology · 05.11.2026

DOI: 10.1111/bjh.70928 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 05.11.2026. Verfasst von Poy Theprungsirikul und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematologic Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Die Arbeit nennt 14 Literaturangaben. Gefördert von: Johnson and Johnson, RJ Corman Multiple Myeloma Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

acute kidney injurydaratumumabmultiple myeloma

Autor:innen und Institutionen

  • Division of Hematologic Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Harvard Medical School, Boston, Massachusetts, USA.
  • Division of Renal Medicine, Department of Medicine, Mass General Brigham, Boston, Massachusetts, USA.
  • Department of Pharmacy, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Division of Hematology-Oncology, Department of Internal Medicine, Dong-A University College of Medicine, Busan, South Korea.
  • Adult Survivorship Program, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

ORCID-Profile: Poy Theprungsirikul, Shahrier Hossain, Ji Hyun Lee, Abdullah Jalal, Tarek H Mouhieddine, Joseph V Bonventre, Paul G Richardson, Shruti Gupta

Förderung

  • Johnson and Johnson
  • RJ Corman Multiple Myeloma Research Fund

Zitieren

APA

Theprungsirikul, P., Chewcharat, A., Takakura, A., Hossain, S., Kim, A., Rubman, M. B., Wells, S. L., Zargari, K. M., Rider, R. S., Lee, J. H., Chowdhury, R. B., Jalal, A., Mouhieddine, T. H., Bonventre, J. V., Richardson, P. G., & Gupta, S. (2026). Dynamic biomarkers of kidney function in patients with newly diagnosed multiple myeloma receiving daratumumab‐based combination therapy. British Journal of Haematology. https://doi.org/10.1111/bjh.70928

Vancouver

Theprungsirikul P, Chewcharat A, Takakura A, Hossain S, Kim A, Rubman MB, et al. Dynamic biomarkers of kidney function in patients with newly diagnosed multiple myeloma receiving daratumumab‐based combination therapy. British Journal of Haematology. 2026. doi:10.1111/bjh.70928

BibTeX
@article{Theprungsirikul2026,
  author = {Theprungsirikul, Poy and Chewcharat, Api and Takakura, Ayumi and Hossain, Shahrier and Kim, Ava and Rubman, Mia B and Wells, Sophia L and Zargari, Kiana M and Rider, Robert S and Lee, Ji Hyun and Chowdhury, Raad B and Jalal, Abdullah and Mouhieddine, Tarek H and Bonventre, Joseph V and Richardson, Paul G and Gupta, Shruti},
  title = {Dynamic biomarkers of kidney function in patients with newly diagnosed multiple myeloma receiving daratumumab‐based combination therapy},
  journal = {British Journal of Haematology},
  year = {2026},
  doi = {10.1111/bjh.70928}
}
Kostenlos starten →